ATROPINE SULFATE

ATROPINE SULFATE was reported 13729 times

ATROPINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCHIZENCEPHALY 13 0.2889
1 VAGINAL FLATULENCE 77 0.2541
2 BEZOLD-JARISCH REFLEX 9 0.2368
3 CEREBRAL HAEMORRHAGE FOETAL 13 0.2131
4 ANTERIOR SPINAL ARTERY SYNDROME 17 0.2024
5 AGITATION POSTOPERATIVE 8 0.1270
6 REBOUND PSYCHOSIS 24 0.1127
7 NEUROMUSCULAR BLOCKADE 13 0.0580
8 RHYTHM IDIOVENTRICULAR 18 0.0554
9 RETINAL OCCLUSIVE VASCULITIS 12 0.0536
10 CREATININE RENAL CLEARANCE INCREASED 39 0.0521
11 FEMALE GENITAL TRACT FISTULA 88 0.0515
12 ANTICHOLINERGIC SYNDROME 79 0.0496
13 SECONDARY HYPOGONADISM 16 0.0485
14 KERATITIS FUNGAL 10 0.0481
15 MULTIPLE DRUG THERAPY 36 0.0477
16 ANTERIOR CHAMBER FLARE 11 0.0472
17 NEUROMUSCULAR BLOCK PROLONGED 17 0.0461
18 AGITATED DEPRESSION 12 0.0417
19 CHOROIDAL DETACHMENT 22 0.0396
20 CHOLINERGIC SYNDROME 25 0.0392
21 ANTERIOR CHAMBER DISORDER 8 0.0348
22 SEASONAL AFFECTIVE DISORDER 11 0.0347
23 HYPERTHERMIA MALIGNANT 50 0.0336
24 BRASH SYNDROME 47 0.0335
25 RADICULOPATHY 88 0.0334
26 HYPOTONY OF EYE 14 0.0333
27 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
28 BACTERIAL TRANSLOCATION 10 0.0315
29 PRESSURE OF SPEECH 20 0.0308
30 PALMOPLANTAR PUSTULOSIS 16 0.0302
31 CHRONIC SINUSITIS 103 0.0274
32 PROCTITIS 76 0.0271
33 SEDATION COMPLICATION 69 0.0270
34 HYPHAEMA 14 0.0268
35 DELUSION OF GRANDEUR 12 0.0267
36 DELAYED RECOVERY FROM ANAESTHESIA 24 0.0253
37 VASOPLEGIA SYNDROME 40 0.0244
38 CORNEAL PERFORATION 15 0.0238
39 ANOSOGNOSIA 18 0.0234
40 IRIS ADHESIONS 12 0.0234
41 FLIGHT OF IDEAS 12 0.0231
42 INFLAMMATORY PAIN 15 0.0221
43 CARDIAC PROCEDURE COMPLICATION 13 0.0214
44 STRESS CARDIOMYOPATHY 123 0.0211
45 MACULAR DEGENERATION 247 0.0207
46 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 9 0.0202
47 KERATIC PRECIPITATES 9 0.0189
48 SUDDEN INFANT DEATH SYNDROME 9 0.0183
49 CATARACT SUBCAPSULAR 11 0.0180
50 CHOROIDAL EFFUSION 14 0.0174
51 STOMA SITE PAIN 25 0.0170
52 ANTIPSYCHOTIC DRUG LEVEL DECREASED 9 0.0169
53 CORNEAL OEDEMA 38 0.0169
54 SOMATIC SYMPTOM DISORDER 18 0.0167
55 SINUS ARREST 26 0.0166
56 RETINAL ISCHAEMIA 10 0.0164
57 SYSTOLIC DYSFUNCTION 17 0.0161
58 CREATININE RENAL CLEARANCE DECREASED 63 0.0157
59 HYPOPYON 13 0.0157
60 BRADYCARDIA FOETAL 13 0.0156
61 QRS AXIS ABNORMAL 12 0.0156
62 MITRAL VALVE CALCIFICATION 10 0.0156
63 INTESTINAL PSEUDO-OBSTRUCTION 13 0.0148
64 JUDGEMENT IMPAIRED 21 0.0144
65 PUPIL FIXED 25 0.0144
66 NODAL RHYTHM 21 0.0143
67 HIRSUTISM 19 0.0143
68 CONSCIOUSNESS FLUCTUATING 14 0.0134
69 CHANGE OF BOWEL HABIT 27 0.0131
70 SICK SINUS SYNDROME 15 0.0130
71 PULSELESS ELECTRICAL ACTIVITY 53 0.0127
72 ANAESTHETIC COMPLICATION 34 0.0126
73 SCLERITIS 20 0.0125
74 CHORIORETINITIS 8 0.0124
75 LARYNGOSPASM 33 0.0123
76 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 26 0.0118
77 NODAL ARRHYTHMIA 10 0.0116
78 HYPERTHERMIA 88 0.0115
79 ELECTROMECHANICAL DISSOCIATION 9 0.0113
80 SCHIZOAFFECTIVE DISORDER 20 0.0112
81 EXCESSIVE GRANULATION TISSUE 9 0.0112
82 NEONATAL HYPOXIA 9 0.0109
83 BRAIN STEM SYNDROME 8 0.0107
84 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
85 SPINAL CORD INJURY 18 0.0103
86 BRONCHIAL SECRETION RETENTION 13 0.0102
87 RENAL FUNCTION TEST ABNORMAL 47 0.0101
88 PRINZMETAL ANGINA 10 0.0101
89 PRODUCT PACKAGING CONFUSION 24 0.0099
90 PULSE ABSENT 46 0.0097
91 COMA SCALE ABNORMAL 28 0.0097
92 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 25 0.0095
93 ARTERIOSPASM CORONARY 38 0.0095
94 NON-CARDIOGENIC PULMONARY OEDEMA 10 0.0095
95 LEFT ATRIAL DILATATION 12 0.0094
96 ANGLE CLOSURE GLAUCOMA 24 0.0094
97 VENTRICULAR FIBRILLATION 104 0.0094
98 OCULAR HYPERTENSION 18 0.0093
99 PUPILLARY REFLEX IMPAIRED 17 0.0092
100 ENDOPHTHALMITIS 55 0.0092
101 CARDIOACTIVE DRUG LEVEL INCREASED 12 0.0091
102 BRADYARRHYTHMIA 15 0.0091
103 APNOEA 71 0.0091
104 MATERNAL EXPOSURE DURING DELIVERY 9 0.0091
105 CARDIAC OUTPUT DECREASED 8 0.0091
106 ANORECTAL DISORDER 18 0.0090
107 APLASTIC ANAEMIA 47 0.0090
108 SALIVARY HYPERSECRETION 89 0.0089
109 MYDRIASIS 114 0.0089
110 ISCHAEMIC HEPATITIS 12 0.0088
111 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 29 0.0087
112 PUPILS UNEQUAL 10 0.0087
113 BRADYCARDIA 458 0.0086
114 HYPOPERFUSION 9 0.0086
115 RETINAL DEGENERATION 11 0.0085
116 TONIC CLONIC MOVEMENTS 11 0.0085
117 ELECTROCARDIOGRAM T WAVE ABNORMAL 13 0.0083
118 BIPOLAR I DISORDER 18 0.0082
119 VAGINAL DISCHARGE 83 0.0082
120 PARAESTHESIA ORAL 118 0.0082
121 SINUS BRADYCARDIA 79 0.0082
122 ANTIPSYCHOTIC DRUG LEVEL INCREASED 23 0.0082
123 CARDIOGENIC SHOCK 117 0.0081
124 COMPARTMENT SYNDROME 21 0.0080
125 ATRIOVENTRICULAR BLOCK COMPLETE 53 0.0079
126 ATRIOVENTRICULAR BLOCK SECOND DEGREE 24 0.0079
127 VENTRICULAR TACHYCARDIA 129 0.0078
128 BLOOD SODIUM INCREASED 21 0.0078
129 ATRIOVENTRICULAR BLOCK FIRST DEGREE 33 0.0076
130 HYPERPARATHYROIDISM SECONDARY 19 0.0076
131 VITRITIS 14 0.0076
132 KOUNIS SYNDROME 17 0.0075
133 THROMBOCYTOPENIC PURPURA 10 0.0073
134 ORAL CANDIDIASIS 95 0.0072
135 TROPONIN I INCREASED 12 0.0072
136 LONG QT SYNDROME 17 0.0071
137 HAEMODYNAMIC INSTABILITY 54 0.0071
138 BLOOD CALCIUM DECREASED 79 0.0070
139 BLOOD CREATININE DECREASED 22 0.0070
140 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 36 0.0070
141 ULCERATIVE KERATITIS 19 0.0069
142 NEPHROGENIC ANAEMIA 32 0.0069
143 PULMONARY VALVE INCOMPETENCE 10 0.0068
144 LEFT VENTRICULAR HYPERTROPHY 29 0.0068
145 ACUTE PULMONARY OEDEMA 38 0.0068
146 BUNDLE BRANCH BLOCK RIGHT 30 0.0065
147 VENTRICULAR EXTRASYSTOLES 65 0.0063
148 VITREOUS HAEMORRHAGE 17 0.0061
149 HYPOVENTILATION 20 0.0061
150 POLYDIPSIA 24 0.0061
151 VENTRICULAR HYPOKINESIA 19 0.0059
152 BUNDLE BRANCH BLOCK LEFT 25 0.0059
153 RESPIRATORY DEPRESSION 72 0.0059
154 AORTIC ARTERIOSCLEROSIS 15 0.0058
155 CHOREA 10 0.0058
156 THERAPEUTIC AGENT TOXICITY 19 0.0057
157 IRIDOCYCLITIS 18 0.0057
158 CYTOMEGALOVIRUS CHORIORETINITIS 11 0.0056
159 ORTHOSTATIC HYPOTENSION 98 0.0056
160 JUGULAR VEIN THROMBOSIS 10 0.0056
161 RESPIRATORY ACIDOSIS 22 0.0056
162 DRUG MONITORING PROCEDURE NOT PERFORMED 10 0.0056
163 WRONG PATIENT RECEIVED PRODUCT 16 0.0055
164 CONDUCTION DISORDER 10 0.0055
165 STRABISMUS 16 0.0054
166 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
167 CREPITATIONS 16 0.0054
168 MYOCARDIAL NECROSIS MARKER INCREASED 9 0.0054
169 PLANTAR FASCIITIS 18 0.0054
170 IRON DEFICIENCY 24 0.0053
171 CONJUNCTIVAL HYPERAEMIA 19 0.0053
172 NEUTROPENIC COLITIS 11 0.0053
173 BLOOD PRESSURE SYSTOLIC DECREASED 24 0.0053
174 DIASTOLIC DYSFUNCTION 16 0.0052
175 SINUS TACHYCARDIA 73 0.0051
176 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
177 ATELECTASIS 49 0.0051
178 ATRIOVENTRICULAR BLOCK 39 0.0050
179 CORNEAL DISORDER 11 0.0050
180 LIMB MASS 11 0.0050
181 TROPONIN INCREASED 38 0.0050
182 HYPOVOLAEMIA 29 0.0050
183 ANAPHYLACTOID REACTION 20 0.0049
184 DERMATITIS ACNEIFORM 29 0.0048
185 CATATONIA 25 0.0048
186 DILATATION VENTRICULAR 10 0.0048
187 TENDON DISORDER 31 0.0047
188 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
189 RETINAL DETACHMENT 43 0.0047
190 MYOCARDIAL ISCHAEMIA 53 0.0047
191 BLOOD CHLORIDE INCREASED 8 0.0046
192 SEDATION 121 0.0046
193 MULTIPLE INJURIES 29 0.0046
194 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 9 0.0046
195 CARDIOMEGALY 56 0.0045
196 CARDIAC ARREST 375 0.0045
197 BRAIN DEATH 14 0.0045
198 OLIGURIA 28 0.0045
199 LARGE INTESTINAL OBSTRUCTION 10 0.0045
200 MUCOSAL DRYNESS 9 0.0045
201 MITRAL VALVE INCOMPETENCE 49 0.0043
202 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
203 TORSADE DE POINTES 33 0.0042
204 LARGE INTESTINE PERFORATION 29 0.0042
205 CARDIOMYOPATHY 61 0.0041
206 VENTRICULAR ARRHYTHMIA 15 0.0041
207 MUSCLE RIGIDITY 49 0.0041
208 MOUTH ULCERATION 86 0.0041
209 STRIDOR 12 0.0041
210 HEART INJURY 10 0.0040
211 INTRAOCULAR PRESSURE INCREASED 51 0.0040
212 TONGUE OEDEMA 15 0.0039
213 ENDOTRACHEAL INTUBATION 11 0.0039
214 PROCEDURAL COMPLICATION 30 0.0039
215 DYSARTHRIA 146 0.0039
216 PROCEDURAL PAIN 107 0.0039
217 ACUTE RESPIRATORY FAILURE 73 0.0038
218 EOSINOPHIL COUNT DECREASED 9 0.0038
219 LACUNAR INFARCTION 9 0.0038
220 HYPOVOLAEMIC SHOCK 18 0.0038
221 HYPOPNOEA 13 0.0037
222 EXOSTOSIS 34 0.0037
223 ANAPHYLACTIC SHOCK 95 0.0037
224 METABOLIC ACIDOSIS 117 0.0037
225 CLONUS 10 0.0037
226 TRICUSPID VALVE INCOMPETENCE 29 0.0036
227 MULTI-ORGAN FAILURE 63 0.0036
228 CLOSTRIDIUM TEST POSITIVE 8 0.0036
229 MYOCARDITIS 41 0.0036
230 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
231 SHOCK 80 0.0035
232 DEPRESSED LEVEL OF CONSCIOUSNESS 137 0.0035
233 PROTEIN TOTAL DECREASED 13 0.0034
234 PARTIAL SEIZURES 18 0.0034
235 ACIDOSIS 26 0.0034
236 ILEUS 42 0.0034
237 NEUROLEPTIC MALIGNANT SYNDROME 40 0.0034
238 CARDIO-RESPIRATORY ARREST 140 0.0033
239 GASTROINTESTINAL INJURY 9 0.0033
240 DISSEMINATED INTRAVASCULAR COAGULATION 47 0.0033
241 POST PROCEDURAL COMPLICATION 64 0.0033
242 FREQUENT BOWEL MOVEMENTS 90 0.0033
243 FAECAL INCONTINENCE 16 0.0033
244 BEHAVIOUR DISORDER 18 0.0033
245 HYPERCAPNIA 10 0.0033
246 DRUG TOXICITY 45 0.0033
247 AORTIC VALVE INCOMPETENCE 14 0.0033
248 FAECALOMA 18 0.0033
249 CEREBRAL ATROPHY 13 0.0033
250 RENAL FAILURE CHRONIC 25 0.0032
251 COLITIS 123 0.0032
252 OBSESSIVE-COMPULSIVE DISORDER 26 0.0032
253 RHABDOMYOLYSIS 135 0.0032
254 FEBRILE NEUTROPENIA 211 0.0032
255 POLYURIA 26 0.0032
256 ECONOMIC PROBLEM 48 0.0032
257 PANCREATIC CARCINOMA METASTATIC 9 0.0032
258 HYPOTHERMIA 32 0.0032
259 ORTHOPNOEA 10 0.0031
260 ILEUS PARALYTIC 14 0.0031
261 TACHYCARDIA 277 0.0031
262 RALES 18 0.0031
263 INTESTINAL ISCHAEMIA 17 0.0031
264 PERIORBITAL OEDEMA 16 0.0031
265 FAILURE TO THRIVE 16 0.0031
266 CARDIOPULMONARY FAILURE 12 0.0031
267 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
268 FOOT DEFORMITY 34 0.0031
269 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
270 BRAIN HERNIATION 9 0.0030
271 RECTAL HAEMORRHAGE 129 0.0030
272 AREFLEXIA 8 0.0030
273 CIRCULATORY COLLAPSE 51 0.0030
274 ENTERITIS 19 0.0030
275 UNRESPONSIVE TO STIMULI 76 0.0029
276 CHEST X-RAY ABNORMAL 9 0.0029
277 ISCHAEMIC CARDIOMYOPATHY 9 0.0029
278 PHLEBITIS 15 0.0029
279 LARYNGEAL OEDEMA 18 0.0029
280 PRODUCT LABEL CONFUSION 17 0.0029
281 HYPOTENSION 581 0.0029
282 AORTIC STENOSIS 10 0.0029
283 TACHYPNOEA 39 0.0029
284 BODY TEMPERATURE DECREASED 28 0.0028
285 RHINOVIRUS INFECTION 11 0.0028
286 POOR PERIPHERAL CIRCULATION 12 0.0028
287 GRANULOCYTOPENIA 16 0.0028
288 VENOUS THROMBOSIS 11 0.0028
289 STUPOR 9 0.0028
290 SCHIZOPHRENIA 34 0.0028
291 ANKLE FRACTURE 43 0.0028
292 NEUROPATHY PERIPHERAL 264 0.0028
293 ORAL PAIN 62 0.0028
294 RESPIRATION ABNORMAL 19 0.0028
295 DROOLING 19 0.0027
296 MENTAL STATUS CHANGES 76 0.0027
297 EYE INFLAMMATION 26 0.0027
298 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
299 DELIRIUM 94 0.0027
300 HYPOTONIA 27 0.0027
301 BLEPHAROSPASM 17 0.0027
302 MUCOSAL INFLAMMATION 70 0.0027
303 HYPOXIA 94 0.0027
304 BRONCHOSPASM 38 0.0027
305 PULMONARY OEDEMA 119 0.0027
306 UVEITIS 36 0.0027
307 HAEMATOCHEZIA 146 0.0026
308 CONGESTIVE CARDIOMYOPATHY 11 0.0026
309 COMA 125 0.0026
310 ISCHAEMIA 12 0.0026
311 PRIAPISM 9 0.0026
312 CYANOSIS 41 0.0026
313 ASPIRATION 28 0.0026
314 CARDIAC FAILURE ACUTE 17 0.0025
315 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
316 NAIL DISCOLOURATION 10 0.0025
317 POISONING DELIBERATE 24 0.0025
318 WRONG PRODUCT ADMINISTERED 17 0.0025
319 HUMERUS FRACTURE 12 0.0025
320 BLINDNESS UNILATERAL 35 0.0025
321 MONOCYTE COUNT INCREASED 9 0.0025
322 DECUBITUS ULCER 20 0.0025
323 DELUSION 38 0.0024
324 TOXIC EPIDERMAL NECROLYSIS 37 0.0024
325 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
326 ENTEROCOLITIS 14 0.0024
327 INFUSION RELATED REACTION 160 0.0024
328 COAGULOPATHY 40 0.0024
329 RESPIRATORY FAILURE 175 0.0024
330 PHOTOPHOBIA 45 0.0024
331 GLAUCOMA 46 0.0024
332 HYDROCEPHALUS 13 0.0024
333 NEUTROPENIC SEPSIS 17 0.0024
334 RESPIRATORY ARREST 65 0.0024
335 HYPERCALCAEMIA 29 0.0023
336 ABSCESS LIMB 10 0.0023
337 SUBSTANCE ABUSE 19 0.0023
338 PROCTALGIA 15 0.0023
339 GANGRENE 14 0.0023
340 PNEUMONIA ASPIRATION 58 0.0023
341 HORDEOLUM 10 0.0023
342 PARALYSIS 33 0.0023
343 END STAGE RENAL DISEASE 42 0.0023
344 BRAIN OEDEMA 29 0.0023
345 CHOLECYSTITIS ACUTE 13 0.0023
346 MUSCLE INJURY 19 0.0023
347 CAROTID ARTERY STENOSIS 8 0.0023
348 HYPERKALAEMIA 80 0.0023
349 HALLUCINATION, VISUAL 48 0.0023
350 PSYCHOTIC DISORDER 67 0.0023
351 RENAL FAILURE ACUTE 96 0.0023
352 AZOTAEMIA 9 0.0023
353 BREATH SOUNDS ABNORMAL 11 0.0022
354 BLOOD CREATINE PHOSPHOKINASE INCREASED 64 0.0022
355 SUSPECTED OFF LABEL USE 10 0.0022
356 PROTEIN URINE PRESENT 11 0.0022
357 TOXICITY TO VARIOUS AGENTS 370 0.0022
358 HYPOALBUMINAEMIA 17 0.0022
359 RESPIRATORY DISTRESS 60 0.0022
360 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
361 EYE OPERATION 10 0.0022
362 VITAMIN D DEFICIENCY 21 0.0022
363 EXTRASYSTOLES 15 0.0021
364 EUPHORIC MOOD 22 0.0021
365 MALNUTRITION 24 0.0021
366 EYE PAIN 120 0.0021
367 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
368 FOOT FRACTURE 40 0.0021
369 HYPERTONIA 12 0.0021
370 SEPTIC SHOCK 91 0.0021
371 HEART RATE DECREASED 73 0.0021
372 TONGUE DISORDER 15 0.0021
373 NYSTAGMUS 11 0.0021
374 PULMONARY HYPERTENSION 43 0.0021
375 DRUG LEVEL INCREASED 34 0.0021
376 PULMONARY HAEMORRHAGE 16 0.0020
377 LUNG INFILTRATION 18 0.0020
378 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
379 BLOOD ALBUMIN DECREASED 16 0.0020
380 OXYGEN SATURATION DECREASED 112 0.0020
381 ANAPHYLACTIC REACTION 110 0.0020
382 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
383 HICCUPS 16 0.0019
384 URINARY RETENTION 65 0.0019
385 COLITIS ULCERATIVE 87 0.0019
386 CACHEXIA 10 0.0019
387 CEREBRAL ISCHAEMIA 10 0.0019
388 PERIPHERAL VASCULAR DISORDER 10 0.0019
389 ACUTE MYOCARDIAL INFARCTION 57 0.0019
390 EJECTION FRACTION DECREASED 30 0.0019
391 MYOCLONUS 23 0.0019
392 DRUG INTERACTION 305 0.0019
393 ARTERIOSCLEROSIS 18 0.0019
394 HAEMODIALYSIS 16 0.0019
395 SKIN ABRASION 9 0.0019
396 BLOOD PRESSURE DECREASED 126 0.0019
397 MIOSIS 15 0.0019
398 THERAPY NON-RESPONDER 84 0.0019
399 PSEUDOMONAS INFECTION 16 0.0019
400 OSTEOPENIA 28 0.0018
401 COGNITIVE DISORDER 86 0.0018
402 PROTHROMBIN TIME PROLONGED 11 0.0018
403 ARRHYTHMIA 87 0.0018
404 PRODUCT ADMINISTRATION ERROR 37 0.0018
405 OESOPHAGITIS 20 0.0018
406 URINE OUTPUT DECREASED 16 0.0018
407 PNEUMOTHORAX 29 0.0018
408 HEPARIN-INDUCED THROMBOCYTOPENIA 9 0.0018
409 AGITATION 134 0.0018
410 SPINAL OSTEOARTHRITIS 16 0.0018
411 RENAL INJURY 54 0.0018
412 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
413 HAEMATOCRIT DECREASED 36 0.0018
414 BLADDER DISORDER 18 0.0018
415 HYPOKALAEMIA 82 0.0018
416 SYNOVITIS 32 0.0018
417 CHOLANGITIS 11 0.0018
418 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
419 AFFECT LABILITY 17 0.0018
420 HYPOPHAGIA 45 0.0018
421 CEREBRAL INFARCTION 43 0.0018
422 GENERALISED ERYTHEMA 10 0.0018
423 NEUTROPHIL COUNT INCREASED 18 0.0018
424 SWELLING OF EYELID 11 0.0018
425 CONSTIPATION 382 0.0017
426 CARDIAC VALVE DISEASE 10 0.0017
427 ANURIA 15 0.0017
428 RHINITIS 14 0.0017
429 BLOOD UREA INCREASED 29 0.0017
430 PETECHIAE 18 0.0017
431 NO THERAPEUTIC RESPONSE 21 0.0017
432 APHASIA 52 0.0017
433 ELECTROLYTE IMBALANCE 20 0.0017
434 SHOCK HAEMORRHAGIC 14 0.0017
435 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
436 HALLUCINATION, AUDITORY 27 0.0017
437 OCULAR DISCOMFORT 19 0.0017
438 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 29 0.0017
439 ACUTE CORONARY SYNDROME 14 0.0017
440 DIVERTICULUM 12 0.0017
441 TOXIC SKIN ERUPTION 17 0.0017
442 NEURALGIA 41 0.0017
443 CARDIAC TAMPONADE 8 0.0017
444 WRONG DRUG ADMINISTERED 15 0.0017
445 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 119 0.0017
446 WALKING AID USER 11 0.0017
447 ELECTROCARDIOGRAM QT PROLONGED 60 0.0017
448 LACTIC ACIDOSIS 54 0.0017
449 RENAL FAILURE 221 0.0017
450 ATRIAL FIBRILLATION 162 0.0017
451 MOBILITY DECREASED 119 0.0017
452 BLOOD PRESSURE SYSTOLIC INCREASED 32 0.0016
453 HAEMATURIA 56 0.0016
454 GINGIVAL PAIN 13 0.0016
455 RENAL TUBULAR NECROSIS 16 0.0016
456 ATRIAL FLUTTER 13 0.0016
457 VITREOUS FLOATERS 16 0.0016
458 PIGMENTATION DISORDER 10 0.0016
459 INTESTINAL OBSTRUCTION 61 0.0016
460 CARDIAC MURMUR 14 0.0016
461 HYPERTENSIVE CRISIS 18 0.0016
462 NECROSIS 9 0.0016
463 ABDOMINAL TENDERNESS 8 0.0016
464 LEUKOCYTOSIS 29 0.0016
465 ANHEDONIA 42 0.0016
466 STATUS EPILEPTICUS 18 0.0016
467 HYPERLIPIDAEMIA 19 0.0016
468 PROTEINURIA 30 0.0016
469 HYPONATRAEMIA 88 0.0016
470 PLEURAL EFFUSION 95 0.0016
471 METASTASES TO LUNG 18 0.0016
472 EMOTIONAL DISORDER 48 0.0016
473 HAEMOLYSIS 12 0.0016
474 METABOLIC DISORDER 9 0.0015
475 DYSPEPSIA 152 0.0015
476 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 12 0.0015
477 SMALL INTESTINAL OBSTRUCTION 19 0.0015
478 METASTASIS 11 0.0015
479 DEMENTIA 43 0.0015
480 VISUAL ACUITY REDUCED 51 0.0015
481 HYPOCALCAEMIA 29 0.0015
482 PERIPHERAL COLDNESS 21 0.0015
483 DISEASE PROGRESSION 180 0.0015
484 MUSCLE TWITCHING 35 0.0015
485 PULMONARY CONGESTION 20 0.0015
486 RENAL CYST 12 0.0015
487 RASH PUSTULAR 11 0.0015
488 HYPOMAGNESAEMIA 21 0.0015
489 ENCEPHALOPATHY 37 0.0015
490 EYE INFECTION 17 0.0015
491 ACUTE KIDNEY INJURY 229 0.0015
492 NEUTROPENIA 203 0.0015
493 FRUSTRATION TOLERANCE DECREASED 12 0.0015
494 HEMIPARESIS 25 0.0015
495 ECCHYMOSIS 10 0.0015
496 CARDIOTOXICITY 13 0.0015
497 DYSKINESIA 59 0.0015
498 HYPERTRANSAMINASAEMIA 10 0.0014
499 BALANCE DISORDER 124 0.0014
500 CHRONIC KIDNEY DISEASE 109 0.0014
501 INTENTIONAL OVERDOSE 92 0.0014
502 WEIGHT FLUCTUATION 15 0.0014
503 ATAXIA 17 0.0014
504 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
505 HYPERTENSION 302 0.0014
506 HEPATOMEGALY 14 0.0014
507 BLINDNESS 58 0.0014
508 ACCIDENTAL OVERDOSE 52 0.0014
509 HAEMATEMESIS 36 0.0014
510 SUDDEN DEATH 15 0.0014
511 THROMBOCYTOPENIA 158 0.0014
512 HYPERHIDROSIS 181 0.0014
513 BRAIN FOG 22 0.0014
514 PARANOIA 24 0.0014
515 INCOHERENT 9 0.0014
516 MYOPATHY 12 0.0014
517 FLANK PAIN 13 0.0014
518 ANGINA UNSTABLE 9 0.0014
519 VISUAL FIELD DEFECT 10 0.0014
520 PREMATURE DELIVERY 22 0.0014
521 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
522 EYELID PTOSIS 14 0.0014
523 FEAR 37 0.0014
524 RESPIRATORY DISORDER 41 0.0014
525 SEIZURE 158 0.0014
526 ANAEMIA 260 0.0014
527 MYASTHENIA GRAVIS 11 0.0014
528 SKIN ULCER 35 0.0014
529 BACTERAEMIA 16 0.0013
530 CONJUNCTIVITIS 25 0.0013
531 PULMONARY EMBOLISM 128 0.0013
532 HEPATOCELLULAR INJURY 19 0.0013
533 OBESITY 21 0.0013
534 EYE MOVEMENT DISORDER 9 0.0013
535 DISORIENTATION 52 0.0013
536 ABDOMINAL PAIN 305 0.0013
537 IRON DEFICIENCY ANAEMIA 12 0.0013
538 GRAND MAL CONVULSION 12 0.0013
539 DEEP VEIN THROMBOSIS 84 0.0013
540 PYREXIA 446 0.0013
541 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
542 DEHYDRATION 169 0.0013
543 INJURY 89 0.0013
544 MUSCLE ATROPHY 16 0.0013
545 HYPERGLYCAEMIA 46 0.0013
546 PSORIATIC ARTHROPATHY 51 0.0013
547 EYE DISCHARGE 13 0.0012
548 ERYTHEMA 257 0.0012
549 OSTEOARTHRITIS 53 0.0012
550 PALLOR 34 0.0012
551 EXTRAPYRAMIDAL DISORDER 31 0.0012
552 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
553 LYMPHOCYTE COUNT DECREASED 22 0.0012
554 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
555 ALANINE AMINOTRANSFERASE INCREASED 76 0.0012
556 HAEMATOMA 32 0.0012
557 GENERAL PHYSICAL HEALTH DETERIORATION 142 0.0012
558 MELAENA 27 0.0012
559 ASCITES 36 0.0012
560 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
561 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 10 0.0012
562 CONFUSIONAL STATE 195 0.0012
563 MULTIPLE ORGAN DYSFUNCTION SYNDROME 34 0.0012
564 LEUKOPENIA 60 0.0012
565 CHOLESTASIS 23 0.0012
566 SPLENOMEGALY 14 0.0012
567 HYPOAESTHESIA ORAL 18 0.0012
568 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
569 CORONARY ARTERY DISEASE 36 0.0012
570 SUBDURAL HAEMATOMA 17 0.0012
571 COLITIS ISCHAEMIC 8 0.0012
572 AORTIC ANEURYSM 9 0.0012
573 HEPATIC STEATOSIS 22 0.0012
574 HEPATIC FUNCTION ABNORMAL 44 0.0012
575 MOTOR DYSFUNCTION 12 0.0012
576 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
577 GINGIVAL BLEEDING 16 0.0012
578 ABORTION INDUCED 11 0.0012
579 PERICARDIAL EFFUSION 27 0.0012
580 OEDEMA 63 0.0012
581 PERITONITIS 24 0.0012
582 PSYCHOLOGICAL TRAUMA 10 0.0012
583 METASTASES TO BONE 19 0.0012
584 HEART RATE IRREGULAR 26 0.0011
585 SEROTONIN SYNDROME 22 0.0011
586 TRANSFUSION 12 0.0011
587 PANCYTOPENIA 64 0.0011
588 DIARRHOEA 739 0.0011
589 HEART RATE INCREASED 113 0.0011
590 METASTASES TO LIVER 20 0.0011
591 HAEMORRHAGE INTRACRANIAL 17 0.0011
592 TUMOUR LYSIS SYNDROME 10 0.0011
593 MUSCULAR WEAKNESS 129 0.0011
594 LOW BIRTH WEIGHT BABY 9 0.0011
595 CARDIAC FAILURE 90 0.0011
596 SEPSIS 125 0.0011
597 THIRST 20 0.0011
598 POISONING 14 0.0011
599 BLOOD POTASSIUM INCREASED 18 0.0011
600 PNEUMONITIS 30 0.0011
601 HALLUCINATION 83 0.0011
602 BRAIN INJURY 11 0.0011
603 LUNG INFECTION 17 0.0011
604 MANIA 18 0.0011
605 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
606 DYSPHAGIA 103 0.0011
607 UROSEPSIS 10 0.0011
608 EMBOLISM 9 0.0011
609 BONE MARROW FAILURE 22 0.0011
610 URINARY INCONTINENCE 32 0.0011
611 BODY TEMPERATURE INCREASED 22 0.0011
612 DYSPHONIA 63 0.0011
613 HAEMORRHOIDS 21 0.0011
614 APPENDICITIS 10 0.0011
615 LACERATION 10 0.0011
616 SOMNOLENCE 214 0.0011
617 HYPERBILIRUBINAEMIA 11 0.0011
618 CARDIAC FAILURE CONGESTIVE 85 0.0011
619 MENTAL DISORDER 46 0.0011
620 SLEEP APNOEA SYNDROME 20 0.0010
621 OSTEOPOROSIS 43 0.0010
622 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
623 DEVICE RELATED INFECTION 16 0.0010
624 BLOOD BILIRUBIN INCREASED 28 0.0010
625 TRANSAMINASES INCREASED 23 0.0010
626 RASH MACULO-PAPULAR 23 0.0010
627 CEREBRAL HAEMORRHAGE 37 0.0010
628 CONVULSION 59 0.0010
629 EOSINOPHILIA 18 0.0010
630 VISION BLURRED 141 0.0010
631 DRUG ABUSE 85 0.0010
632 C-REACTIVE PROTEIN INCREASED 37 0.0010
633 VOMITING 477 0.0010
634 HAEMOGLOBIN DECREASED 104 0.0010
635 BLOOD CREATININE INCREASED 66 0.0010
636 DYSPNOEA EXERTIONAL 38 0.0010
637 CHOLECYSTITIS 12 0.0010
638 PULMONARY MASS 15 0.0010
639 COLON CANCER 15 0.0010
640 OVERDOSE 217 0.0010
641 EPISTAXIS 75 0.0010
642 BLOOD POTASSIUM DECREASED 30 0.0010
643 LOSS OF CONSCIOUSNESS 127 0.0010
644 DECREASED APPETITE 230 0.0010
645 RENAL IMPAIRMENT 83 0.0010
646 ILL-DEFINED DISORDER 60 0.0010
647 SUBARACHNOID HAEMORRHAGE 10 0.0010
648 NEUTROPHIL COUNT DECREASED 40 0.0010
649 TYPE 2 DIABETES MELLITUS 33 0.0010
650 ASPHYXIA 8 0.0010
651 EYE HAEMORRHAGE 13 0.0010
652 GENERALISED OEDEMA 12 0.0010
653 OCULAR HYPERAEMIA 46 0.0010
654 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
655 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53 0.0010
656 MOVEMENT DISORDER 31 0.0010
657 HYPOKINESIA 14 0.0010
658 PREMATURE BABY 29 0.0010
659 DIARRHOEA HAEMORRHAGIC 9 0.0010
660 NEOPLASM 11 0.0010
661 RESTLESSNESS 35 0.0010
662 SPEECH DISORDER 50 0.0010
663 MADAROSIS 11 0.0009
664 FALL 315 0.0009
665 STEVENS-JOHNSON SYNDROME 21 0.0009
666 CATARACT 56 0.0009
667 ABSCESS 15 0.0009
668 PULMONARY FIBROSIS 18 0.0009
669 DYSTONIA 18 0.0009
670 SKIN LACERATION 10 0.0009
671 WEIGHT DECREASED 255 0.0009
672 BEDRIDDEN 12 0.0009
673 POLLAKIURIA 38 0.0009
674 OFF LABEL USE 797 0.0009
675 PHARYNGEAL OEDEMA 14 0.0009
676 GASTROINTESTINAL PAIN 10 0.0009
677 OEDEMA PERIPHERAL 110 0.0009
678 THERAPY PARTIAL RESPONDER 14 0.0009
679 VISUAL IMPAIRMENT 111 0.0009
680 HEPATIC FAILURE 27 0.0009
681 BLOOD URINE PRESENT 17 0.0009
682 LIVER FUNCTION TEST ABNORMAL 26 0.0009
683 EMPHYSEMA 9 0.0009
684 JAUNDICE 24 0.0009
685 FISTULA 10 0.0009
686 NAUSEA 704 0.0009
687 SYNCOPE 89 0.0009
688 SECRETION DISCHARGE 11 0.0009
689 FLUSHING 89 0.0009
690 GASTRITIS 23 0.0009
691 HYPERSOMNIA 25 0.0009
692 ORAL HERPES 17 0.0009
693 DYSPNOEA 491 0.0009
694 SWOLLEN TONGUE 27 0.0009
695 PRESYNCOPE 21 0.0009
696 TENDERNESS 9 0.0009
697 EYELID OEDEMA 10 0.0009
698 POST PROCEDURAL HAEMORRHAGE 10 0.0009
699 NEEDLE ISSUE 25 0.0009
700 STOMATITIS 52 0.0009
701 DRUG RESISTANCE 22 0.0009
702 NEUROTOXICITY 15 0.0009
703 ANOREXIA 11 0.0009
704 DEVICE OCCLUSION 12 0.0009
705 DIPLOPIA 22 0.0008
706 PAIN 519 0.0008
707 CHEST PAIN 156 0.0008
708 INTERNATIONAL NORMALISED RATIO INCREASED 24 0.0008
709 MUSCULOSKELETAL CHEST PAIN 13 0.0008
710 PANCREATITIS 44 0.0008
711 FACE OEDEMA 14 0.0008
712 MENTAL IMPAIRMENT 20 0.0008
713 SUICIDE ATTEMPT 50 0.0008
714 HAEMOPTYSIS 23 0.0008
715 GASTROENTERITIS 12 0.0008
716 ASTHENIA 306 0.0008
717 DRY MOUTH 66 0.0008
718 SENSORY DISTURBANCE 13 0.0008
719 AGRANULOCYTOSIS 15 0.0008
720 PHARYNGITIS 10 0.0008
721 BLOOD PRESSURE ABNORMAL 16 0.0008
722 RED BLOOD CELL COUNT DECREASED 23 0.0008
723 ANGINA PECTORIS 23 0.0008
724 SYRINGE ISSUE 14 0.0008
725 FATIGUE 622 0.0008
726 PNEUMONIA 257 0.0008
727 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
728 CONTUSION 76 0.0008
729 HYPOTHYROIDISM 25 0.0008
730 LETHARGY 45 0.0008
731 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
732 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
733 MATERNAL EXPOSURE DURING PREGNANCY 69 0.0008
734 RHINORRHOEA 50 0.0008
735 EAR PAIN 15 0.0008
736 URINARY TRACT INFECTION 131 0.0008
737 TREMOR 126 0.0008
738 FLUID OVERLOAD 11 0.0008
739 MEDICATION ERROR 42 0.0008
740 PRODUCTIVE COUGH 36 0.0008
741 POLYNEUROPATHY 9 0.0008
742 PLATELET COUNT DECREASED 80 0.0007
743 CONDITION AGGRAVATED 227 0.0007
744 ANXIETY 212 0.0007
745 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
746 SLEEP DISORDER 52 0.0007
747 PRODUCT DISPENSING ERROR 16 0.0007
748 DIABETES MELLITUS 56 0.0007
749 CELLULITIS 37 0.0007
750 IMPAIRED GASTRIC EMPTYING 10 0.0007
751 MALIGNANT NEOPLASM PROGRESSION 75 0.0007
752 UNEVALUABLE EVENT 55 0.0007
753 TOOTHACHE 13 0.0007
754 MASS 10 0.0007
755 DRUG INEFFECTIVE 932 0.0007
756 RETCHING 15 0.0007
757 BLOOD PRESSURE INCREASED 107 0.0007
758 ABDOMINAL DISTENSION 73 0.0007
759 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
760 SKIN DISORDER 23 0.0007
761 RASH MACULAR 24 0.0007
762 EYE IRRITATION 39 0.0007
763 MALAISE 297 0.0007
764 DEATH 582 0.0007
765 WHEEZING 40 0.0007
766 HEPATOTOXICITY 15 0.0007
767 ISCHAEMIC STROKE 12 0.0007
768 EYE SWELLING 25 0.0007
769 PAIN IN JAW 19 0.0007
770 EYE DISORDER 22 0.0007
771 CHOKING 13 0.0007
772 ARTHROPATHY 37 0.0007
773 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
774 PARAESTHESIA 104 0.0007
775 FUNGAL INFECTION 22 0.0007
776 ABASIA 16 0.0006
777 SCAR 11 0.0006
778 PRODUCT USE IN UNAPPROVED INDICATION 159 0.0006
779 TREATMENT NONCOMPLIANCE 35 0.0006
780 HYPOGLYCAEMIA 31 0.0006
781 GAIT DISTURBANCE 122 0.0006
782 BLOOD SODIUM DECREASED 12 0.0006
783 DIALYSIS 9 0.0006
784 RIB FRACTURE 13 0.0006
785 CARDIOVASCULAR DISORDER 16 0.0006
786 AMNESIA 41 0.0006
787 FEELING JITTERY 12 0.0006
788 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
789 BLOOD PRESSURE FLUCTUATION 15 0.0006
790 ARTHRITIS 49 0.0006
791 EPILEPSY 19 0.0006
792 THROMBOSIS 50 0.0006
793 ERUCTATION 12 0.0006
794 AGGRESSION 31 0.0006
795 WHITE BLOOD CELL COUNT DECREASED 67 0.0006
796 APATHY 9 0.0006
797 LUNG DISORDER 30 0.0006
798 CHEST DISCOMFORT 62 0.0006
799 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
800 CHILLS 70 0.0006
801 CYSTITIS 19 0.0006
802 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
803 ANGER 20 0.0006
804 FLUID RETENTION 30 0.0006
805 NEPHROLITHIASIS 27 0.0006
806 BLISTER 33 0.0006
807 HEADACHE 368 0.0006
808 ACUTE HEPATIC FAILURE 8 0.0006
809 IRRITABILITY 35 0.0006
810 CHOLELITHIASIS 19 0.0006
811 GASTRIC ULCER 11 0.0006
812 NERVOUS SYSTEM DISORDER 18 0.0006
813 CHROMATURIA 13 0.0006
814 HAEMORRHAGE 60 0.0006
815 ROAD TRAFFIC ACCIDENT 24 0.0006
816 DYSURIA 21 0.0006
817 EMOTIONAL DISTRESS 69 0.0006
818 BACK PAIN 132 0.0006
819 COLD SWEAT 10 0.0006
820 ULCER 9 0.0006
821 LYMPHADENOPATHY 20 0.0006
822 GALLBLADDER DISORDER 10 0.0006
823 ABNORMAL BEHAVIOUR 22 0.0006
824 PRURITUS GENERALISED 12 0.0006
825 MUSCULOSKELETAL PAIN 29 0.0006
826 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
827 BONE DISORDER 10 0.0005
828 CYTOKINE RELEASE SYNDROME 11 0.0005
829 HEPATITIS 14 0.0005
830 EXPOSURE DURING PREGNANCY 34 0.0005
831 SKIN LESION 15 0.0005
832 STAPHYLOCOCCAL INFECTION 18 0.0005
833 COUGH 153 0.0005
834 TASTE DISORDER 11 0.0005
835 MUSCLE SPASMS 99 0.0005
836 MYOCARDIAL INFARCTION 94 0.0005
837 HEAD INJURY 17 0.0005
838 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
839 TOOTH LOSS 11 0.0005
840 DRUG ADMINISTRATION ERROR 16 0.0005
841 ANGIOEDEMA 23 0.0005
842 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
843 IMPAIRED HEALING 17 0.0005
844 EATING DISORDER 11 0.0005
845 COMPLETED SUICIDE 43 0.0005
846 ABDOMINAL PAIN LOWER 13 0.0005
847 THROAT IRRITATION 23 0.0005
848 VERTIGO 31 0.0005
849 EYE PRURITUS 17 0.0005
850 LOWER RESPIRATORY TRACT INFECTION 23 0.0005
851 ALOPECIA 99 0.0005
852 DRY EYE 25 0.0005
853 LACRIMATION INCREASED 15 0.0005
854 INTENTIONAL SELF-INJURY 10 0.0005
855 HYPERSENSITIVITY 91 0.0005
856 BRONCHITIS 36 0.0005
857 INFECTION 70 0.0005
858 BACTERIAL INFECTION 9 0.0005
859 HYPOAESTHESIA 72 0.0005
860 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
861 GASTROINTESTINAL DISORDER 43 0.0005
862 DEPRESSION 109 0.0005
863 DERMATITIS 10 0.0005
864 SWELLING FACE 31 0.0005
865 LABORATORY TEST ABNORMAL 14 0.0005
866 LIVER DISORDER 21 0.0005
867 ABDOMINAL PAIN UPPER 97 0.0005
868 DYSGEUSIA 35 0.0005
869 CARDIAC DISORDER 44 0.0005
870 TARDIVE DYSKINESIA 13 0.0005
871 NEOPLASM PROGRESSION 16 0.0005
872 LOCALISED INFECTION 11 0.0005
873 PALPITATIONS 53 0.0005
874 DIZZINESS 225 0.0005
875 VIRAL INFECTION 15 0.0005
876 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
877 JOINT SWELLING 54 0.0004
878 PANCREATITIS ACUTE 10 0.0004
879 OSTEONECROSIS OF JAW 11 0.0004
880 THROAT TIGHTNESS 12 0.0004
881 RASH ERYTHEMATOUS 21 0.0004
882 CEREBROVASCULAR ACCIDENT 74 0.0004
883 PLASMA CELL MYELOMA 17 0.0004
884 INSOMNIA 116 0.0004
885 RASH 189 0.0004
886 PAIN IN EXTREMITY 127 0.0004
887 NECK PAIN 24 0.0004
888 INFLAMMATION 22 0.0004
889 DISCOMFORT 26 0.0004
890 FEELING HOT 26 0.0004
891 LIMB DISCOMFORT 13 0.0004
892 POOR QUALITY SLEEP 9 0.0004
893 VAGINAL HAEMORRHAGE 18 0.0004
894 LUNG NEOPLASM MALIGNANT 17 0.0004
895 DRY SKIN 55 0.0004
896 MEMORY IMPAIRMENT 56 0.0004
897 LIVER INJURY 10 0.0004
898 TOOTH DISORDER 9 0.0004
899 HIP FRACTURE 13 0.0004
900 SKIN EXFOLIATION 34 0.0004
901 AGEUSIA 10 0.0004
902 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
903 HEPATIC ENZYME INCREASED 27 0.0004
904 SWELLING 37 0.0004
905 FEELING COLD 11 0.0004
906 INTERSTITIAL LUNG DISEASE 19 0.0004
907 GAIT INABILITY 13 0.0004
908 RASH GENERALISED 10 0.0004
909 BLOOD CHOLESTEROL INCREASED 18 0.0004
910 CRYING 14 0.0004
911 RESPIRATORY TRACT INFECTION 10 0.0004
912 URTICARIA 64 0.0004
913 ABDOMINAL DISCOMFORT 64 0.0004
914 WEIGHT INCREASED 85 0.0004
915 ARTHRALGIA 157 0.0004
916 NIGHT SWEATS 12 0.0004
917 PRURITUS 142 0.0004
918 HERPES ZOSTER 21 0.0004
919 RENAL DISORDER 17 0.0004
920 WOUND 10 0.0004
921 PANIC ATTACK 13 0.0004
922 OROPHARYNGEAL PAIN 33 0.0004
923 BONE DENSITY DECREASED 11 0.0004
924 TINNITUS 16 0.0003
925 SKIN DISCOLOURATION 16 0.0003
926 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
927 JOINT STIFFNESS 9 0.0003
928 NASAL CONGESTION 20 0.0003
929 EAR INFECTION 9 0.0003
930 FLATULENCE 19 0.0003
931 OSTEONECROSIS 11 0.0003
932 BLOOD GLUCOSE INCREASED 61 0.0003
933 DRUG-INDUCED LIVER INJURY 10 0.0003
934 PERIPHERAL SWELLING 49 0.0003
935 BLOOD GLUCOSE DECREASED 15 0.0003
936 DYSSTASIA 9 0.0003
937 BONE PAIN 18 0.0003
938 SINUSITIS 31 0.0003
939 INTENTIONAL PRODUCT MISUSE 26 0.0003
940 MUSCULOSKELETAL STIFFNESS 26 0.0003
941 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
942 RASH PRURITIC 16 0.0003
943 PRODUCT USE ISSUE 54 0.0003
944 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
945 MYELOSUPPRESSION 10 0.0003
946 ASTHMA 31 0.0003
947 DISEASE RECURRENCE 13 0.0003
948 PRODUCT DOSE OMISSION ISSUE 79 0.0003
949 COVID-19 47 0.0003
950 DEVICE ISSUE 24 0.0003
951 INFLUENZA LIKE ILLNESS 22 0.0003
952 HOT FLUSH 20 0.0003
953 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
954 SUICIDAL IDEATION 24 0.0003
955 UNDERDOSE 19 0.0003
956 ADVERSE DRUG REACTION 23 0.0003
957 HYPOACUSIS 11 0.0003
958 FEELING ABNORMAL 60 0.0003
959 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
960 DEVICE BREAKAGE 10 0.0002
961 DEPRESSED MOOD 13 0.0002
962 INFLUENZA 27 0.0002
963 HOSPITALISATION 37 0.0002
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
965 DRUG INTOLERANCE 23 0.0002
966 MYALGIA 40 0.0002
967 BURNING SENSATION 16 0.0002
968 INCORRECT DOSE ADMINISTERED 52 0.0002
969 NO ADVERSE EVENT 41 0.0002
970 DISTURBANCE IN ATTENTION 12 0.0002
971 SURGERY 13 0.0002
972 TREATMENT FAILURE 18 0.0002
973 NERVOUSNESS 11 0.0002
974 ECZEMA 11 0.0002
975 ADVERSE EVENT 19 0.0002
976 ILLNESS 21 0.0002
977 DEVICE MALFUNCTION 14 0.0002
978 PSORIASIS 26 0.0002
979 PRODUCT QUALITY ISSUE 27 0.0002
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
981 THERAPY INTERRUPTED 14 0.0002
982 DRUG WITHDRAWAL SYNDROME 17 0.0002
983 MIGRAINE 18 0.0002
984 MULTIPLE SCLEROSIS 9 0.0002
985 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
986 ACNE 14 0.0002
987 PRODUCT DOSE OMISSION 11 0.0002
988 COLORECTAL CANCER 8 0.0002
989 NEOPLASM MALIGNANT 11 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
991 PRODUCT STORAGE ERROR 10 0.0001
992 NASOPHARYNGITIS 21 0.0001
993 DRUG DEPENDENCE 16 0.0001
994 INJECTION SITE PAIN 30 0.0001
995 RHEUMATOID ARTHRITIS 11 0.0001
996 DRUG DOSE OMISSION 9 0.0001